KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Historical Holders from Q2 2024 to Q3 2025

Symbol
KPRX on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
3,640,761
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
616,169
Holdings value
$1,714,712
% of all portfolios
0%
Number of holders
17
Number of buys
9
Number of sells
-7
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% $1,095,537 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
Nantahala Capital Management, LLC 9.99% 0% $1,018,394 +$160,860 363,712 +18.8% Nantahala Capital Management, LLC 30 Sep 2025
HIRSCHMAN ORIN 8.5% $843,332 255,555 Orin Hirschman 31 Dec 2024
Nantahala Capital Partners Limited Partnership 5.3% $569,115 189,705 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 08 Aug 2025
Alyeska Investment Group, L.P. 2.5% $249,572 75,628 Alyeska Investment Group, L.P. 31 Dec 2024
GOLDMAN SACHS GROUP INC 0% $429 130 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024

Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 616,169 $1,714,712 -$910,084 $2.78 17
2025 Q2 931,843 $2,683,707 -$1,054,952 $2.88 16
2025 Q1 1,285,403 $3,869,063 +$78,079 $3.01 18
2024 Q4 1,259,459 $4,164,082 +$76,847 $3.3 16
2024 Q3 1,213,569 $4,441,661 +$905,961 $3.66 18
2024 Q2 966,044 $4,057,360 +$4,057,360 $4.2 15